BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/7/2021 10:14:28 AM | Browse: 397 | Download: 603
 |
Received |
|
2020-08-29 17:56 |
|
Peer-Review Started |
|
2020-08-25 13:44 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-11-16 21:39 |
|
Revised |
|
2020-12-01 17:37 |
|
Second Decision |
|
2020-12-15 09:34 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-12-17 01:03 |
|
Articles in Press |
|
2020-12-17 01:03 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-01-04 02:57 |
|
Publish the Manuscript Online |
|
2021-01-07 10:14 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Therapeutic and Diagnostic Guidelines |
| Article Title |
Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maham Farshidpour, Monjur Ahmed, Shilpa Junna and Juanita L Merchant |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Maham Farshidpour, MD, Doctor, Inpatient Medicine, Banner University of Medical Center, 1501 N Campbell Ave, Tucson, AZ 85724, United States. mfarshidpour@email.arizona.edu |
| Key Words |
Myeloid-derived suppressor cells; Gastrointestinal cancers; Immune checkpoint inhibitors; Tumor progression |
| Core Tip |
In patients with cancer, the levels of myeloid-derived suppressor cells (MDSCs) are presumed to be of prognostic and predictive value. Recent studies have shown that MDSCs appear to be independent prognostic factors in gastrointestinal cancer. In addition, therapeutics that target MDSCs have been shown to enhance anti-tumor immune responses in animal models. Consequently, a better understanding of the role and mechanism of action of MDSCs in the tumor microenvironment may aid in the development of novel immune-targeted therapies. |
| Publish Date |
2021-01-07 10:14 |
| Citation |
Farshidpour M, Ahmed M, Junna S, Merchant JL. Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review. World J Gastrointest Oncol 2021; 13(1): 1-11 |
| URL |
https://www.wjgnet.com/1948-5204/full/v13/i1/1.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v13.i1.1 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
